Catherine Tsilfidis

Catherine Tsilfidis

Company: Ottawa Hospital Research Institute

Job title: Senior Scientist

Bio:

Senior Scientist, Ottawa Hospital Research Institute
Don and Joy Maclaren Chair for Vision Research
Associate Professor, Departments of Ophthalmology and Cellular and Molecular Medicine, University of Ottawa

Seminars:

XIAP Anti-Apoptotic Gene Therapy for the Treatment of Glaucoma 1:50 pm

Using gene therapy to target apoptosis of the cell (the final endpoint for many ocular diseases) is a general strategy that doesn't target a specific mutation The X-linked inhibitor of apoptosis (XIAP) is able to block apoptosis by preventing caspase activation, but can also block necroptosis and inflammasome formation XIAP gene therapy is effective in…Read more

day: Preclinical 4

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.